Latest Director Remuneration News

Cosmos Exploration has completed its merger with EAU Lithium, securing key partnerships and technology to progress lithium development in Bolivia. The company also committed to acquiring a German-built pilot plant to support its VULSORB® extraction technology.

Azzuro Resources has locked in a major copper-gold discovery at its newly acquired Red Hill project in Mongolia, confirming a high-grade VMS system over nearly 550 metres of strike with significant expansion potential.

PYC Therapeutics has made significant progress across its four RNA therapeutic programs, including dose escalation approvals in its Polycystic Kidney Disease trial and orphan drug designation for its Retinitis Pigmentosa candidate, supported by a robust cash position of $669 million.

Sunstone Metals reported strong exploration progress in the June 2026 quarter at its Bramaderos and El Palmar gold-copper projects in Ecuador, highlighted by consistent long mineralised intersections and a $10 million capital raise.

Alliance Nickel has kicked off vat leach testing at its NiWest Nickel-Cobalt Project, aiming to slash capital costs, while raising $2.4 million through a partial entitlement offer and extending loan facilities to mid-2027.

Deep Yellow Limited has accelerated progress at its flagship Tumas uranium project in Namibia, awarding major construction contracts and pushing detailed engineering close to 80% completion ahead of a Final Investment Decision expected in Q4 2026. Exploration activities in Namibia and Australia continue to build the company’s resource pipeline amid a strengthening uranium market.

S2 Resources secured new tenements, completed heritage and aeromagnetic surveys, and obtained drilling approvals across WA, NSW, and Victoria, maintaining a robust cash position of A$18.57 million.

I Synergy Group has appointed Anson Heng as Executive Chairman and Managing Director to spearhead its strategic cooperation with Macau Direch, formalised through a non-binding MoU targeting blockchain, AI, and digital asset initiatives.

Entropy Neurodynamics has reported breakthrough Phase 2 clinical results for its intravenous psilocin therapy in treatment-resistant Binge Eating Disorder, alongside strong Phase 2a data in Irritable Bowel Syndrome and a new US patent filing.

Buru Energy pushes forward with its Rafael Gas Project development, securing A$5.3 million in funding and progressing environmental approvals while navigating executive leadership changes.

Nexalis Therapeutics has issued share rights to directors in lieu of fees, with vesting contingent on successful Phase 2 clinical trial completion, aiming to conserve cash for ongoing drug development.

Group 6 Metals set a new quarterly record processing 77,953 tonnes at its Dolphin Tungsten Mine, producing 21,297 MTUs of tungsten concentrate despite lower feed grades. The company strengthened its cash position to $49.5 million and commenced underground mining, aiming to improve grades and recovery in coming quarters.